181 related articles for article (PubMed ID: 36760377)
1. Dasatinib-associated chylothorax in a pediatric patient with chronic myeloid leukemia: a case report and literature review.
Liu Q; Fu J; Zhang A
Transl Cancer Res; 2023 Jan; 12(1):194-200. PubMed ID: 36760377
[TBL] [Abstract][Full Text] [Related]
2. Dasatinib-induced chylothorax in a patient with chronic myeloid leukaemia: a case report and literature review.
Hsu CC; Hsu JF; Wu KL
Respirol Case Rep; 2021 Jun; 9(6):e00753. PubMed ID: 33976882
[TBL] [Abstract][Full Text] [Related]
3. Dasatinib-induced chylothorax: report of a case and review of the literature.
Chen B; Wu Z; Wang Q; Li W; Cheng D
Invest New Drugs; 2020 Oct; 38(5):1627-1632. PubMed ID: 32248338
[TBL] [Abstract][Full Text] [Related]
4. Dasatinib-induced Chylothorax in Chronic Myelogenous Leukemia in Pediatric Patient: Report of a Case and Review of Literature.
Hickman K; Diaz E; Graham R; Adams R; Ngwube A
J Pediatr Hematol Oncol; 2020 Oct; 42(7):e665-e667. PubMed ID: 31688632
[TBL] [Abstract][Full Text] [Related]
5. Dasatinib-induced massive left chylothorax in a patient with chronic myeloid leukemia.
Makimoto G; Misawa M; Maeda Y; Kiura K
Respir Med Case Rep; 2022; 37():101662. PubMed ID: 35585905
[TBL] [Abstract][Full Text] [Related]
6. Spotlight on dasatinib in chronic myeloid leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia.
McCormack PL; Keam SJ
BioDrugs; 2012 Feb; 26(1):61-4. PubMed ID: 22233429
[TBL] [Abstract][Full Text] [Related]
7. [Chylothorax Related with Dasatinib in the Treatment of Chronic Myeloid Leukemia: Report of 3 Cases].
Yang L; Lu N; Jing Y; Yu L
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Oct; 24(5):1348-1353. PubMed ID: 27784355
[TBL] [Abstract][Full Text] [Related]
8. Dasatinib-induced Chylothorax in Chronic Myeloid Leukemia.
Alqattan Y; Ali S; Almohammad R; Kayali N; Alhuraiji A
Gulf J Oncolog; 2022 Sep; 1(40):74-77. PubMed ID: 36448074
[TBL] [Abstract][Full Text] [Related]
9. Dasatinib: a review of its use in the treatment of chronic myeloid leukaemia and Philadelphia chromosome-positive acute lymphoblastic leukaemia.
McCormack PL; Keam SJ
Drugs; 2011 Sep; 71(13):1771-95. PubMed ID: 21902298
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic Pitfalls of Chylothorax After Dasatinib Treatment of Chronic Myeloid Leukemia.
Kelly RL; Bae JY; D'Annunzio S; Montanari F
Am J Case Rep; 2022 Nov; 23():e938319. PubMed ID: 36444127
[TBL] [Abstract][Full Text] [Related]
11. A Dasatinib-Induced Chylothorax Persisting After the Discontinuation of Dasatinib.
Bradt N; Olbrechts F; Alexander P; Salembier A
Eur J Case Rep Intern Med; 2022; 9(10):003601. PubMed ID: 36415836
[TBL] [Abstract][Full Text] [Related]
12. Dasatinib-induced chylothorax: An unusual presentation of a common adverse event-A case report with literature review.
Paul T; Ellahie AY; Almohtasib YS; Sinha U; El Omri H
EJHaem; 2021 Aug; 2(3):545-550. PubMed ID: 35844702
[TBL] [Abstract][Full Text] [Related]
13. Dasatinib in Pediatric Patients With Chronic Myeloid Leukemia in Chronic Phase: Results From a Phase II Trial.
Gore L; Kearns PR; de Martino ML; Lee ; De Souza CA; Bertrand Y; Hijiya N; Stork LC; Chung NG; Cardos RC; Saikia T; Fagioli F; Seo JJ; Landman-Parker J; Lancaster D; Place AE; Rabin KR; Sacchi M; Swanink R; Zwaan CM
J Clin Oncol; 2018 May; 36(13):1330-1338. PubMed ID: 29498925
[TBL] [Abstract][Full Text] [Related]
14. Recurrent Chylous Pleural Effusions in a Patient Treated With Dasatinib.
Nasir SA; Calavia Liano H; Manfredi C
Cureus; 2022 Aug; 14(8):e27778. PubMed ID: 36106302
[TBL] [Abstract][Full Text] [Related]
15. Dasatinib-related chylothorax.
Huang YM; Wang CH; Huang JS; Yeh KY; Lai CH; Wu TH; Chang PH; Chang PH; Chang YS; Lan YJ
Turk J Haematol; 2015 Mar; 32(1):68-72. PubMed ID: 25805678
[TBL] [Abstract][Full Text] [Related]
16. Dasatinib-Induced Colitis with Rectal Sparing in a Patient with Chronic Myeloid Leukemia (Chronic Phase) on Dasatinib as an Upfront Therapy: Case Report.
Maat Z; Mushtaq K; Yassin MA
Case Rep Oncol; 2021; 14(3):1441-1446. PubMed ID: 34899234
[TBL] [Abstract][Full Text] [Related]
17. Simultaneous manifestation of pleural effusion and acute renal failure associated with dasatinib: a case report.
Kaiafa G; Kakaletsis N; Savopoulos C; Perifanis V; Giannouli A; Papadopoulos N; Zisekas S; Hatzitolios AI
J Clin Pharm Ther; 2014 Feb; 39(1):102-5. PubMed ID: 24188312
[TBL] [Abstract][Full Text] [Related]
18. Dasatinib: from treatment of imatinib-resistant or -intolerant patients with chronic myeloid leukemia to treatment of patients with newly diagnosed chronic phase chronic myeloid leukemia.
Abbott BL
Clin Ther; 2012 Feb; 34(2):272-81. PubMed ID: 22285209
[TBL] [Abstract][Full Text] [Related]
19. Dasatinib: a tyrosine kinase inhibitor for the treatment of chronic myelogenous leukemia and philadelphia chromosome-positive acute lymphoblastic leukemia.
Steinberg M
Clin Ther; 2007 Nov; 29(11):2289-308. PubMed ID: 18158072
[TBL] [Abstract][Full Text] [Related]
20. Drug-induced chylothorax as a rare pleural complication in dasatinib therapy for chronic myeloid leukaemia.
Ng IK; Ruparel M; Chan EH; Khoo KL
J R Coll Physicians Edinb; 2024 Mar; 54(1):44-47. PubMed ID: 38486345
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
